• HOME
  • OUR PRODUCTS
    • IKOSA AI: Train your own AI applications
    • IKOSA Prisma: Choose a ready-made application from our portfolio
      • Most popular: CAM Assay
      • Cell Painting
    • IKOSA Portal: Manage your projects and teams
    • Pricing and Licensing
  • ABOUT US
    • About us
    • Our team
    • Contact
  • RESOURCES
    • Podcast
    • Blog
    • Publications
    • Scientific Posters
    • Knowledge Base
  • START FREE TRIAL
  • BOOK A DEMO

Automated Morphological Profiling via Deep Learning-Based Segmentation for High-Throughput Phenotypic Screening

Apr 22, 2026 | Cell Painting, Publications, Use case

This study presents a fully automated workflow for morphological profiling of microscopy images using deep learning–based segmentation built on the IKOSA platform. The system was developed to reduce the manual setup and technical expertise typically required in...

In Vitro and In Ovo CAM Model Evaluation of Periosteum-Derived Micrografts

Apr 8, 2026 | CAM, IKOSA AI, Publications

Periosteum-derived micrografts show strong potential to enhance vascularization when combined with commonly used bone substitute materials. In this study, micrografts containing mesenchymal stem cell-like cell populations were evaluated in the chorioallantoic membrane...

Phenogenomics reveals the ecology and evolution of Trichoderma fungi for sustainable agriculture

Mar 5, 2026 | Fungi REPAINT Assay, Publications

This study, published in Nature Microbiology, presents a comprehensive phenogenomic map of the fungal genus Trichoderma, which is widely used in sustainable agriculture for crop protection and soil health. By combining large-scale genomic sequencing with...

SynBBB™: AI/ML-Enhanced Standardization and Predictive Monitoring of Human-Relevant Blood-Brain Barrier-on-Chip for CNS Drug Discovery

Oct 28, 2025 | IKOSA AI, Posters

The blood-brain barrier (BBB) is a critical determinant of central nervous system (CNS) drug transport, safety, and efficacy. Conventional models often fail to capture its complexity, leading to translational gaps. SynVivo’s SynBBB™ platform recreates physiologically...

Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalizationin pleural mesothelioma

Jun 26, 2025 | Network Formation Assay, Publications

This study explores a novel therapeutic strategy for pleural mesothelioma, a highly aggressive cancer with limited treatment options. The researchers investigated the combined inhibition of VEGFR2, a key regulator of angiogenesis, and PD-L1, an immune checkpoint...
« Older Entries

Imprint
Terms of service
Privacy policy

  • Contacts
  • Press

Login to IKOSA
Knowledge Base
SlideShare

  • Follow
  • Follow
  • Follow
  • Follow

© 2024 KOLAIDO GmbH. IKOSA® is an EU registered trademark.